Patents Assigned to Universite D'Auvergne
  • Patent number: 8404707
    Abstract: The present invention relates to a series of novel imidazo[1,2-?]pyrrolo[3,2-c]pyridines (or also named 6H-1,3a,6-Tri-aza-?y-indacenes) and derivatives thereof, according to formula: (I); The present invention also relates to processes for the preparation of imidazo[1,2-?]pyrrolo[3,2-c]pyridines, their use as. a, medicine, their use to treat or prevent viral infections and their use to manufacture a medicine to treat or prevent viral infections, particularly infections with viruses belonging to the family of the Flaviviridae and more preferably infections with Bovine Viral Diarrhea virus (BVDV).
    Type: Grant
    Filed: December 14, 2007
    Date of Patent: March 26, 2013
    Assignees: Universite d'Auvergne Clermont 1, Universite Francois Rabelais Tours, Kathlieke Universiteit Leuven
    Inventors: Johan Neyts, Jan Paeshuyse, Olivier Chavignon, Jean-Michel Chezal, Vincent Gaumet, Alain Gueiffier, Jean-Claude Teulade
  • Publication number: 20130064775
    Abstract: This invention relates to riluzole for use in the treatment or prevention of adverse effects associated with the administration of anticancer agents having neurotoxic effects, such as, for example, platinum salts, taxanes and periwinkle alkaloids.
    Type: Application
    Filed: March 2, 2011
    Publication date: March 14, 2013
    Applicant: UNIVERSITE D'AUVERGNE CLERMONT I
    Inventors: Jérôme Busserolles, Abdelkrim Alloui, Michel Lazdunski, Alain Eschalier
  • Patent number: 8257085
    Abstract: The invention relates to a device for simulating the stomach of a monogastric mammal or of a human being that includes at least two compression chambers (C2, C3) connected together by an intermediate chamber. Each compression chamber (C2, C3) includes a piston (72, 73) adapted for urging the content of a compression chamber (C2, C3) towards the other compression chamber (C2, C3). The device includes means (20) capable of generating turbulent flow of the device content when passing through the intermediate chamber (C8). The intermediate chamber (C8) is formed in an intermediate block (8) provided with an access means (11a, 12, 16) for supplying products (12) and/or tapping the content of the device at any moment of the operation cycle thereof.
    Type: Grant
    Filed: October 21, 2008
    Date of Patent: September 4, 2012
    Assignee: Universite d'Auvergne Clermont I
    Inventors: Monique Alric, Sylvain Georges Jean Denis
  • Publication number: 20110044899
    Abstract: A compound of formula (I): in which R1 represents a hydrogen atom, an optionally labelled halogen, a radionuclide or a Sn[(C1-C4)alkyl]3 group, Ar represents an aryl group or a heteroaryl group, R9 represents a hydrogen atom, a (C1-C4) alkyl group or forms together with the group R1—Ar a ring fused with the Ar group, A represents a group of formula (?) or (?): R3 and R4 independently represent a hydrogen atom, a (C1-C6)alkyl group, a (C1-C6) alkenyl group or a group of formula (y): wherein R11 represents an optionally labelled halogen, a radionuclide, an aryl or heteroaryl group optionally substituted by an optionally labelled halogen, a radionuclide, a —NO2 group, a —NR5R6 group, a N+R5R6R7X? group, or a —OSO2R12 group, and their addition salts with pharmaceutically acceptable acids.
    Type: Application
    Filed: January 28, 2009
    Publication date: February 24, 2011
    Applicants: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES, UNIVERSITE D'AUVERGNE CLERMONT 1, LABORATOIRES CYCLOPHARMA
    Inventors: Jean-Michel Chezal, Frederic Dolle, Jean-Claude Madelmont, Aurelie Maisonial, Elisabeth Miot-Noirault, Nicole Moins, Janine Papon, Bertrand Kuhnast, Bertrand Tavitian, Raphael Boisgard
  • Publication number: 20100093863
    Abstract: A method of using L-citrulline of the formula (I) for preparing a cosmetic composition, a food or nutraceutic composition or a pharmaceutical composition for treating diseases related to an increase in protein carbonylation, in particular for treating neurodegenerative diseases such as Alzheimer's or Parkinson's disease.
    Type: Application
    Filed: March 20, 2008
    Publication date: April 15, 2010
    Applicants: UNIVERSITE PARIS DESCARTESURE, INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE, ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS, UNIVERSITE D' AUVERGNE
    Inventors: Christophe Moinard, Stephane Walrand, Yves Boirie, Luc Cynober
  • Publication number: 20100093781
    Abstract: The present invention relates to a series of novel imidazo[1,2-?]pyrrolo[3,2-c]pyridines (or also named 6H-1,3a,6-Tri-aza-?y-indacenes) and derivatives thereof, according to formula: (I); The present invention also relates to processes for the preparation of imidazo[1,2-?]pyrrolo[3,2-c]pyridines, their use as. a, medicine, their use to treat or prevent viral infections and their use to manufacture a medicine to treat or prevent viral infections, particularly infections with viruses belonging to the family of the Flaviviridae and more preferably infections with Bovine Viral Diarrhea virus (BVDV).
    Type: Application
    Filed: December 14, 2007
    Publication date: April 15, 2010
    Applicants: Universite D'Auvergne Clermont 1, Universite Francois Rabelais Tours, Katholieke Universiteit Leuven
    Inventors: Johan Neyts, Jan Paeshuyse, Olivier Chavignon, Jean-Michel Chezal, Vincent Gaumet, Alain Gueiffier, Jean-Claude Teulade
  • Publication number: 20100061928
    Abstract: The present invention relates to the use of a compound of formula (I): in which R1 represents a radionuclide, Ar represents an aromatic nucleus, m is an integer varying from 2 to 4, R2 and R3 represent, independently of one another, a hydrogen atom, a (C1-C6)alkyl group, a (C1-C6)alkenyl group or an aryl group chosen from a phenyl, benzyl, imidazolyl, pyridyl, pyrimidinyl, pyrazinyl, indolyl, indazolyl, furyl and thienyl group, and their addition salts with pharmaceutically acceptable acids, in the preparation of a radiopharmaceutical composition intended for the diagnosis and/or treatment of melanoma.
    Type: Application
    Filed: July 27, 2007
    Publication date: March 11, 2010
    Applicants: Institut National De La Sante et De La Recherche Medicale (INSERM), Universite D'Auvergne Clermont 1
    Inventors: Jean-Claude Madelmont, Jean-Michel Chezal, Nicole Moins, Jean-Claude Teulade, Olivier Chavignon
  • Patent number: 7285100
    Abstract: A system for representation and analysis of pressure variables in a patient including a plurality of pressure sensors; a signal processor connected to process signals emitted by the sensors, wherein the process comprises a multiplicity of inputs for receiving analog signals from the sensors, wherein each input is connected to a sampling circuit providing a digital signal used by a calculator for performing processing steps comprising: resampling displayed or recorded signals, analyzing the frequency of sampled signals in relation to a range of target frequencies recorded in a memory, for the display and recording of temporal variations of the signals corresponding to slow waves of the signals, and determination of temporal shifts between the slow waves corresponding to two distinct inputs; and a display that shows variations in the signals.
    Type: Grant
    Filed: July 23, 2002
    Date of Patent: October 23, 2007
    Assignee: Universite d'Auvergne-Clermont-Ferrand 1
    Inventor: Jean-Jacques Lemaire
  • Patent number: 7160250
    Abstract: A method of analyzing biological pressure signals in a patient including obtaining arterial blood pressure, cerebral blood flow rate and intracranial pressure signals from the patient, and analyzing frequencies of the signals in relation to a range of target frequencies corresponding to at least one of type-B slow waves, infra-B waves and ultra-B waves; and an apparatus for analyzing biological pressure signals in a patient including an acquisition module, located adjacent to the patient and having input channels that receive signals from an arterial blood pressure (ABP) sensor, a cerebral blood flow rate (CBF) sensor, and an intracranial pressure (ICP) sensor; an analysis module that performs frequency analysis of the signals from a target frequency selected from the group consisting of type B slow waves corresponding to a frequency between 8×10?3 hertz and 50×10?3 hertz, infra-B waves corresponding to a frequency lower than 8×10?3 hertz, and ultra-B waves corresponding to a frequency including between 50×10
    Type: Grant
    Filed: July 23, 2002
    Date of Patent: January 9, 2007
    Assignee: Universite D'Auvergne
    Inventor: Jean-Jacques Lemaire
  • Publication number: 20050130169
    Abstract: The invention concerns a method for detecting micro-organisms constituting a flora of micro-organisms, whereof at least part of the elements has a common operon. The invention is characterised in that it consists in identifying the elements of said flora by studying the intergenetic sequence of said operon, and the support exhibiting nucleic acids capable of hybridizing said intergenetic sequence.
    Type: Application
    Filed: November 28, 2003
    Publication date: June 16, 2005
    Applicants: UNIVERSITE D'AUVERGNE, DIGESTAR
    Inventors: Pierre-Charles Romond, Michel Renaud, Johanne Renaud, Mathias Renaud, Monique Alric, Olivier Meiniel, Lionel Ballut